Infliximab in pediatric rheumatology patients: a retrospective analysis of infusion reactions and severe adverse events during 2246 infusions over 12 years

FA Aeschlimann, KD Hofer, EC Schneider… - The Journal of …, 2014 - jrheum.org
Objective. To describe infusion reactions (IR) and severe adverse events (SAE) associated
with infliximab (IFX) in pediatric patients with rheumatologic and ocular inflammatory …

Prevalence of anti-infliximab antibodies and their associated co-factors in children with refractory arthritis and/or uveitis: a retrospective longitudinal cohort study

…, F Angst, KD Hofer, EC Schneider… - The Journal of …, 2017 - jrheum.org
Objective. Infliximab (IFX) is a monoclonal tumor necrosis factor-α–inhibiting antibody used
in children with refractory arthritis and uveitis. Immunogenicity is associated with a lack of …

[HTML][HTML] Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland

…, R Carlomagno, E Cannizzaro Schneider… - Frontiers in …, 2022 - frontiersin.org
Introduction: Children with rheumatic diseases (PRD) have an increased infection risk.
Vaccinations are effective to avoid vaccine-preventable diseases. This study aimed to assess the …

THU0600 High vaccine coverage rates are not enough: vaccination delay and risk for vaccine-preventable diseases in paediatric patients with rheumatic diseases …

T Welzel, T Zumbrunn, J Bonhoeffer, EC Schneider… - 2018 - ard.bmj.com
Background Paediatric patients with rheumatic diseases (PedRD) are more susceptible to
invasive infectious diseases, due to their underlying disease, high disease activity and …

A5: Detectable Anti‐Infliximab Antibodies in Children Treated with Infliximab for Rheumatic Diseases

FA Aeschlimann, K Hofer, EC Schneider… - Arthritis & …, 2014 - Wiley Online Library
Background/Purpose: Infliximab (IFX) is a monoclonal TNF‐alpha inhibiting antibody which
is frequently used to treat children with refractory arthritis and uveitis. The most frequent and …

Primary care provider beliefs and recommendations about colorectal cancer screening in four healthcare systems

…, BB Green, NT Cannizzaro, JL Schneider… - Cancer Prevention …, 2020 - AACR
Primary care provider's (PCP) perceptions of colorectal cancer screening test effectiveness
and their recommendations for testing intervals influence patient screening uptake. Few large …

Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and …

A Cannizzaro, L Ronat, LM El Haffaf… - … journal of geriatric …, 2023 - Wiley Online Library
Objective Neuropsychiatric symptoms (NPS) are common in mild cognitive impairment (MCI)
and even more in Alzheimer's disease (AD). The symptom‐based cluster including …

[HTML][HTML] Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part three: Athens, Greece. 14-17 September 2017

…, M Harjacek, E Adank, EC Schneider, E Abdalla… - Pediatric …, 2017 - Springer
Objectives: We report the case of a 17, 5 years old girl presenting with recurrent episodes of
fever starting at the age of 16. Methods: A 17, 5 years old girl was referred to our department …

Influence of pulping process on the emission of formaldehyde and volatile organic acids from pulps and medium density fibreboards (MDF)

E Roffael, B Dix, T Schneider - Holz als Roh-und Werkstoff, 2007 - infona.pl
… Furthermore, the release of formaldehyde from CTMP is lower than that from TMP due to
Cannizzaro reaction catalysed by alkali. Moreover, binderless fibreboards from CTMP are …

Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2

M Schneider, E Drews, M Koch - Behavioural pharmacology, 2005 - journals.lww.com
… Furthermore, PPI deficits induced by both chronic pubertal and by acute administration of
WIN in adult rats can be reduced by the dopamine antagonist haloperidol ( Schneider and Koch…